The effect of electroconvulsive therapy on cerebral monoamine oxidase A expression in treatment-resistant depression investigated using positron emission tomography-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The effect of electroconvulsive therapy on cerebral monoamine oxidase A expression in treatment-resistant depression investigated using positron emission tomography

Published:2019-05 Issue:3 Volume:12 Page:714-723
ISSN:1935-861X
Container-title:Brain Stimulation
language:en
Short-container-title:Brain Stimulation

Author:

Baldinger-Melich Pia,Gryglewski Gregor,Philippe Cécile,James Gregory M.,Vraka Chrysoula,Silberbauer Leo,Balber Theresa,Vanicek Thomas,Pichler Verena,Unterholzner Jakob,Kranz Georg S.,Hahn Andreas,Winkler Dietmar,Mitterhauser Markus,Wadsak Wolfgang,Hacker Marcus,Kasper Siegfried,Frey Richard,Lanzenberger Rupert^ORCID

Funder

Angelini

AOP Orphan Pharmaceuticals AG

AstraZeneca

Celegne GmbH

Eli Lilly

Janssen-Cilag Pharma GmbH

KRKA-Pharma

Lundbeck A/S

Neuraxpharm

Pfizer

Pierre Fabre

Schwabe and Servier

Shire

Dr. Willmar Schwabe GmbH

Orphan Pharmaceuticals AG

Roche Austria GmbH

GE Healthcare

Bayer. R

Bristol-Myers Squibb

Sandoz

Eli Lilly, and Janssen

Lundbeck

Medizin Medien Austria

ProMente

Austrian Science Fund

Austrian Academy of Sciences at the Medical University of Vienna

Publisher

Elsevier BV

Subject

Clinical Neurology,Biophysics,General Neuroscience

Reference78 articles.

1. The origins of electroconvulsive therapy: prof. Bini's first report on ECT;Faedda;J Affect Disord,2010

2. Speed of response and remission in major depressive disorder with acute electroconvulsive therapy (ECT): a Consortium for Research in ECT (CORE) report;Husain;J Clin Psychiatr,2004

3. World federation of societies of biological psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, Part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders;Bauer;World J Biol Psychiatr,2013

4. Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study;Souery;J Clin Psychiatr,2007

5. European Group for the Study of Resistant Depression (GSRD) - where have we gone so far: review of clinical and genetic findings;Schosser;Eur Neuropsychopharmacol,2012

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neurobiological mechanisms of electroconvulsive therapy for depression: Insights into hippocampal volumetric increases from clinical and preclinical studies;Journal of Neurochemistry;2024-01-18

2. Sargassum horneri Extract Attenuates Depressive-like Behaviors in Mice Treated with Stress Hormone;Antioxidants;2023-10-10

3. Effects of electroconvulsive therapy on cerebral A1 adenosine receptor availability: a PET study in patients suffering from treatment-resistant major depressive disorder;Frontiers in Psychiatry;2023-07-14

4. Comparison of Monoamine Oxidase-A, Aβ Plaques, Tau, and Translocator Protein Levels in Postmortem Human Alzheimer’s Disease Brain;International Journal of Molecular Sciences;2023-06-28

5. Impact of genetic variants within serotonin turnover enzymes on human cerebral monoamine oxidase A in vivo;Translational Psychiatry;2023-06-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3